Literature DB >> 28555673

The dichotomous nature of T helper 17 cells.

Brigitta Stockinger1, Sara Omenetti1.   

Abstract

T helper 17 (TH17) cells have been extensively studied since their discovery 10 years ago, primarily because of their known pathogenic role in many inflammatory diseases. Substantial progress has been made in understanding their development, regulation and functional activities, and genome-wide transcriptomic analysis has identified regulatory networks, nodes and interactions that provide vital clues for further studies. In this Review, we describe recent studies that have revealed the dichotomous nature of TH17 cells, which on the one hand allows these cells to be pathogenic drivers of inflammatory disorders and on the other hand allows them to support the integrity of the intestinal barrier in a non-inflammatory manner.

Entities:  

Mesh:

Year:  2017        PMID: 28555673     DOI: 10.1038/nri.2017.50

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  97 in total

Review 1.  The aryl hydrocarbon receptor: multitasking in the immune system.

Authors:  Brigitta Stockinger; Paola Di Meglio; Manolis Gialitakis; João H Duarte
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

Review 2.  Oxygen metabolism and barrier regulation in the intestinal mucosa.

Authors:  Louise E Glover; J Scott Lee; Sean P Colgan
Journal:  J Clin Invest       Date:  2016-08-08       Impact factor: 14.808

3.  High incidence of T-cell lymphomas in mice deficient in the retinoid-related orphan receptor RORgamma.

Authors:  Eiichiro Ueda; Shogo Kurebayashi; Morito Sakaue; Michael Backlund; Beverly Koller; Anton M Jetten
Journal:  Cancer Res       Date:  2002-02-01       Impact factor: 12.701

4.  TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.

Authors:  Mandy J McGeachy; Kristian S Bak-Jensen; Yi Chen; Cristina M Tato; Wendy Blumenschein; Terrill McClanahan; Daniel J Cua
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

Review 5.  Cytokine-mediated regulation of antimicrobial proteins.

Authors:  Jay K Kolls; Paul B McCray; Yvonne R Chan
Journal:  Nat Rev Immunol       Date:  2008-11       Impact factor: 53.106

6.  Obesity Drives Th17 Cell Differentiation by Inducing the Lipid Metabolic Kinase, ACC1.

Authors:  Yusuke Endo; Hikari K Asou; Nao Matsugae; Kiyoshi Hirahara; Kenta Shinoda; Damon J Tumes; Hirotake Tokuyama; Koutaro Yokote; Toshinori Nakayama
Journal:  Cell Rep       Date:  2015-07-30       Impact factor: 9.423

7.  De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells.

Authors:  Luciana Berod; Christin Friedrich; Amrita Nandan; Jenny Freitag; Stefanie Hagemann; Kirsten Harmrolfs; Aline Sandouk; Christina Hesse; Carla N Castro; Heike Bähre; Sarah K Tschirner; Nataliya Gorinski; Melanie Gohmert; Christian T Mayer; Jochen Huehn; Evgeni Ponimaskin; Wolf-Rainer Abraham; Rolf Müller; Matthias Lochner; Tim Sparwasser
Journal:  Nat Med       Date:  2014-10-05       Impact factor: 53.440

8.  A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.

Authors:  Caroline Sutton; Corinna Brereton; Brian Keogh; Kingston H G Mills; Ed C Lavelle
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

9.  Autoimmune Renal Disease Is Exacerbated by S1P-Receptor-1-Dependent Intestinal Th17 Cell Migration to the Kidney.

Authors:  Christian F Krebs; Hans-Joachim Paust; Sonja Krohn; Tobias Koyro; Silke R Brix; Jan-Hendrik Riedel; Patricia Bartsch; Thorsten Wiech; Catherine Meyer-Schwesinger; Jiabin Huang; Nicole Fischer; Philipp Busch; Hans-Willi Mittrücker; Ulrich Steinhoff; Brigitta Stockinger; Laura Garcia Perez; Ulrich O Wenzel; Matthias Janneck; Oliver M Steinmetz; Nicola Gagliani; Rolf A K Stahl; Samuel Huber; Jan-Eric Turner; Ulf Panzer
Journal:  Immunity       Date:  2016-11-15       Impact factor: 31.745

10.  Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells.

Authors:  David R Withers; Matthew R Hepworth; Xinxin Wang; Emma C Mackley; Emily E Halford; Emma E Dutton; Clare L Marriott; Verena Brucklacher-Waldert; Marc Veldhoen; Judith Kelsen; Robert N Baldassano; Gregory F Sonnenberg
Journal:  Nat Med       Date:  2016-02-15       Impact factor: 53.440

View more
  123 in total

1.  TMP778, a selective inhibitor of RORγt, suppresses experimental autoimmune uveitis development, but affects both Th17 and Th1 cell populations.

Authors:  Cancan Lyu; So Jin Bing; Wambui S Wandu; Biying Xu; Guangpu Shi; Samuel J Hinshaw; Mercedes Lobera; Rachel R Caspi; Lin Lu; Jianfei Yang; Igal Gery
Journal:  Eur J Immunol       Date:  2018-10-09       Impact factor: 5.532

2.  CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer.

Authors:  Tao Wang; Quan Zhou; Han Zeng; Hongyu Zhang; Zhaopei Liu; Jialiang Shao; Zewei Wang; Ying Xiong; Jiajun Wang; Qi Bai; Yu Xia; Yiwei Wang; Li Liu; Yu Zhu; Le Xu; Bo Dai; Jianming Guo; Yuan Chang; Xiang Wang; Jiejie Xu
Journal:  Cancer Immunol Immunother       Date:  2020-05-04       Impact factor: 6.968

Review 3.  Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer.

Authors:  Matteo Bellone; Arianna Brevi; Samuel Huber
Journal:  Microbiol Mol Biol Rev       Date:  2020-03-04       Impact factor: 11.056

4.  A Summary of the Fifth Annual Virology Education HIV Microbiome Workshop.

Authors:  Scott Sherrill-Mix; Kaleigh Connors; Grace M Aldrovandi; Jason M Brenchley; Charles Boucher; Frederic D Bushman; Ronald G Collman; Satya Dandekar; Nichole R Klatt; Laurel A Lagenaur; Roger Paredes; Gilda Tachedjian; Jim A Turpin; Alan L Landay; Mimi Ghosh
Journal:  AIDS Res Hum Retroviruses       Date:  2020-09-07       Impact factor: 2.205

5.  Unique Tailoring of Th17 at the Gingival Oral Mucosal Barrier.

Authors:  J E Konkel; N M Moutsopoulos
Journal:  J Dent Res       Date:  2017-10-13       Impact factor: 6.116

6.  The dichotomy of T helper 17 cells in cancer.

Authors:  Lekh N Dahal
Journal:  Nat Rev Immunol       Date:  2017-08-21       Impact factor: 53.106

7.  Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α-dependent pathways.

Authors:  Ioannis Morianos; Aikaterini I Trochoutsou; Gina Papadopoulou; Maria Semitekolou; Aggelos Banos; Dimitris Konstantopoulos; Antigoni Manousopoulou; Maria Kapasa; Ping Wei; Brett Lomenick; Elise Belaidi; Themis Kalamatas; Klinta Karageorgiou; Triantafyllos Doskas; Federica Sallusto; Fan Pan; Spiros D Garbis; Francisco J Quintana; Georgina Xanthou
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-14       Impact factor: 11.205

8.  Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patients.

Authors:  Yingkai Li; Jeffrey T Guptill; Melissa A Russo; Janice M Massey; Vern C Juel; Lisa D Hobson-Webb; James F Howard; Manisha Chopra; Weibin Liu; John S Yi
Journal:  Exp Neurol       Date:  2018-11-22       Impact factor: 5.330

Review 9.  The role of transforming growth factor β in T helper 17 differentiation.

Authors:  Song Zhang
Journal:  Immunology       Date:  2018-05-08       Impact factor: 7.397

10.  E3 Ubiquitin Ligase Von Hippel-Lindau Protein Promotes Th17 Differentiation.

Authors:  Alisha Chitrakar; Scott A Budda; Jacob G Henderson; Robert C Axtell; Lauren A Zenewicz
Journal:  J Immunol       Date:  2020-07-20       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.